Severe cutaneous drug toxicity following enfortumab vedotin treatment for metastatic urothelial carcinoma.

导出 LinkOut

翻译打印收藏纠错

作者： Christina D,Enescu ^[1] ; Christina,Artz ^[2] ; Anna,Axelson ^[2]

作者单位： Department of Dermatology, Wayne State University School of Medicine, Detroit, Michigan. ^[1] Department of Dermatology, Henry Ford Health System, Detroit, Michigan. ^[2]

关键词 EV, enfortumab vedotin MMAE, monomethyl auristatin E SJS, Stevens-Johnson syndrome TEN, toxic epidermal necrolysis UC, urothelial carcinoma cutaneous drug toxicity enfortumab vedotin exfoliative dermatitis general dermatology

DOI 10.1016/j.jdcr.2022.01.005

PMID 35242967

发布时间 2022-03-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JAAD case reports

2022年21卷

140-143页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Severe cutaneous drug toxicity following enfortumab vedotin treatment for metastatic urothelial carcinoma.

JAAD case reports

相似文献

JAAD case reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Severe cutaneous drug toxicity following enfortumab vedotin treatment for metastatic urothelial carcinoma.

JAAD case reports

相似文献

JAAD case reports

相关期刊

检索历史清除